About
Jeanne Volatron is the CEO and co-founder of EVerZom, a French biotech focused on exosome-based regenerative therapies. EVerZom's public materials describe her as a PhD in Physics and one of the founders who began working on the company in 2018 before its formal creation in 2019. In 2025, she publicly represented EVerZom in its €10 million financing and a research collaboration with GENFIT focused on regenerative technology for ACLF.
Areas of interest
biotechexosomesregenerative medicineinflammatory diseasesCrohn's diseaseliver diseasecell and gene therapy